glycopyrrolate
glycopyrrolate is listed in the FDA National Drug Code directory with 37 NDC codes, marketed under brand names including Glycopyrrolate, GLYCOPYRROLATE, glycopyrrolate. Available dosage forms: tablet, injection, solution, injection, solution, liquid.
Drug Details
- Generic Name
- glycopyrrolate
- Brand Names
- Glycopyrrolate, GLYCOPYRROLATE, glycopyrrolate, GLYRX-PF, Cuvposa
- Application Number
- ANDA040653
- Sponsor
- Bryant Ranch Prepack
- NDC Codes
- 37
- Dosage Forms
- TABLET, INJECTION, SOLUTION, INJECTION, SOLUTION, LIQUID
- Routes
- ORAL, INTRAMUSCULAR, INTRAVENOUS
- Active Ingredients
- GLYCOPYRROLATE
Indications and Usage
1 INDICATIONS AND USAGE Glycopyrrolate oral solution is indicated to reduce chronic severe drooling in patients aged 3 to 16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy). Glycopyrrolate is an anticholinergic indicated to reduce chronic severe drooling in patients aged 3 to 16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy). ( 1 )